Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy
- 1 January 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9249) , 43-44
- https://doi.org/10.1016/s0140-6736(00)03574-1
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patientsBlood, 2000
- Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factorBone Marrow Transplantation, 2000
- Myelodysplastic Syndrome and Acute Myelogenous Leukemia as a Late Clonal Complication in Children With Acquired Aplastic AnemiaBlood, 1997
- Immunosuppression in Aplastic Anemia — Postponing the Inevitable?New England Journal of Medicine, 1991